Tessera Defense and Homeland Security Inc. (HLSQ)
HLSQ trades on NYSE in Health Care, Biotechnology: Biological Products (No Diagnostic Substances). Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.2600
-7.08% on the day
Market cap
$2.3M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | HLSQ on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Country | Not reported by the screener |
| IPO year | 2019 |
| SEC CIK | 0001739174 |
| SEC industry code | Services-Prepackaged Software |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2026-07-27 |
| Latest annual report AMENDMENT NO. 1 TO FORM 10-K | 10-K/A | 2026-04-30 |
| Latest quarterly / interim QUARTERLY REPORT | 10-Q | 2026-08-19 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-13 |
| Latest proxy DEFINITIVE ADDITIONAL MATERIALS | DEFA14A | 2026-10-08 |
Source: SEC EDGAR submissions feed, 580 recent filings. All filings on EDGAR.
Peers in Biotechnology: Biological Products (No Diagnostic Substances)
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SLXN | Silexion Therapeutics Corp | $0.1760 | -1.24% | $2.5M |
| VIVS | VivoSim Labs Inc. | $0.1742 | +0.12% | $2.9M |
| SCNI | Scinai Immunotherapeutics Ltd. | $1.23 | +6.03% | $1.7M |
| CLDI | Calidi Biotherapeutics Inc. | $0.8999 | -5.26% | $3.3M |
| PMCB | PharmaCyte Biotech Inc. | $0.3559 | -2.52% | $3.8M |
| CRIS | Curis Inc. | $0.6149 | -4.42% | $1.3M |
| LIMN | Liminatus Pharma Inc. | $3.41 | -1.16% | $4.6M |
| BTTC | Black Titan Corporation | $0.4380 | -10.70% | $6.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier